Vol 33 No 1

Many college students who engage in binge drinking, experiment with illicit drugs, and/or misuse pharmaceuticals will go through this rite of passage relatively unscathed. However, others will not.

In the years of transition to adulthood, obtaining adequate assessment and treatment for ADHD is often more difficult than at any other point during the lifespan.

The research on electronic aggression among college students indicates that it is highly prevalent, with over 93% of college students reporting some negative effects due to electronic victimization.

Strategies to decrease the chances that individuals will fall through the cracks in the college years.

The authors examine the potential areas of concern during the postpartum period, as well as practical approaches to differential diagnosis and treatment.

Could right-to-die laws result in people requesting death, even in the face of of potentially treatable health problems?

A report of initiatives that have raised awareness of and promoted data sharing and data transparency in order to advance science and improve public health and health care.

We psychiatrists are best equipped to design and participate in programs to help diminish workplace triggers for burnout. And, even more important, we are well equipped to recognize signs of burnout in ourselves.

A personal account by a psychiatrist who has battled depression.

An overview of the interface between HIV/AIDS infection and mental illness.

Tears track his leathered face like seawater spilled from a sinking hull...

Gun violence by alienated, disgruntled individuals isn't new. So what changes may help account for our recent spate of mass shootings?

This article reviews the different categories of elder abuse, emphasizing the role and requirements for psychiatrists, with a focus on financial elder abuse.

The first episode of psychosis represents a critical juncture in the treatment of schizophrenia. Here: A synopsis of 2-year outcomes from the NIMH Recovery After an Initial Schizophrenia Episode (RAISE) Early Treatment Program.

Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.

Psychiatrists increasingly recognize that not all treatments for depression are created equal-but in this case, an entirely different diagnosis came to light.